Please try another search
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a non-invasive blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from patient's blood plasma to diagnose the presence of breast cancer cells in a patient’s body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Jayne Andrea Shaw | - | 2010 | Co-Founder & Executive Chairman |
Jonathan Alfred Grey Trollip | 66 | 2020 | Independent Non-Executive Director |
Ronald Anthony Phillips | - | 2010 | Co-Founder & Non-Executive Director |
Sanjay Warrier | - | 2022 | Scientific Advisory Board Member |
Mary Rickard | - | 2022 | Scientific Advisory Board Member |
David Gregory Darling | - | 2024 | Non-Executive Director |
Craig Gedye | - | - | Scientific Advisory Board Member |
Kim Ekroos | - | - | Scientific Advisory Board Member |
Peter Meikle | - | - | Scientific Advisory Board Member |
Mark Burrows | 80 | 2021 | Independent Non-Executive Director |
John G. Hurrell | - | 2022 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review